| Thomas J Boeve, MD | |
|
870 State Farm Rd, Boone, NC 28607-4861 | |
| (828) 264-4545 | |
| Not Available |
| Full Name | Thomas J Boeve |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | 870 State Farm Rd, Boone, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093740714 | NPI | - | NPPES |
| 1093740714 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2018-02322 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watauga Medical Center | Boone, NC | Hospital |
| Sagewest Health Care | Riverton, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverton Physician Practices, Llc | 8426954496 | 14 |
| Blue Ridge Ear Nose And Throat Inc | 6901719434 | 9 |
News Archive
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.
In 2012 Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly publishing business of John Wiley & Sons, Inc., will begin publishing 44 titles new to its journal program, including 16 new launches and 40 journals published in collaboration with societies or other organizations.
Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
If you need health care in rural Michigan, and you don't have insurance or money, you can turn to a free clinic - like the one University of Michigan medical students run each Saturday in the tiny town of Pinckney. Fewer people need this kind of help these days, because of new insurance options made possible by the Affordable Care Act.
› Verified 3 days ago
| Entity Name | Riverton Physician Practices, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205875614 PECOS PAC ID: 8426954496 Enrollment ID: O20040505000232 |
News Archive
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.
In 2012 Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly publishing business of John Wiley & Sons, Inc., will begin publishing 44 titles new to its journal program, including 16 new launches and 40 journals published in collaboration with societies or other organizations.
Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
If you need health care in rural Michigan, and you don't have insurance or money, you can turn to a free clinic - like the one University of Michigan medical students run each Saturday in the tiny town of Pinckney. Fewer people need this kind of help these days, because of new insurance options made possible by the Affordable Care Act.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas J Boeve, MD 870 State Farm Rd, Boone, NC 28607-4861 Ph: (828) 264-4545 | Thomas J Boeve, MD 870 State Farm Rd, Boone, NC 28607-4861 Ph: (828) 264-4545 |
News Archive
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.
In 2012 Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly publishing business of John Wiley & Sons, Inc., will begin publishing 44 titles new to its journal program, including 16 new launches and 40 journals published in collaboration with societies or other organizations.
Crimson Life Sciences, a division of TransPerfect and the world's only ISO 13485 and ISO 14971-certified translation provider, today announced the publication of their Japan Medical Device Digest, a free monthly report that provides English translations of Japanese-language news items.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
If you need health care in rural Michigan, and you don't have insurance or money, you can turn to a free clinic - like the one University of Michigan medical students run each Saturday in the tiny town of Pinckney. Fewer people need this kind of help these days, because of new insurance options made possible by the Affordable Care Act.
› Verified 3 days ago
Dr. Charles W Ford Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 870 State Farm Rd, Suite 101, Boone, NC 28607 Phone: 828-264-4545 Fax: 282-264-4544 | |
Dr. Andrew Thomas Voglewede, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 870 State Farm Rd, Suite 101, Boone, NC 28607 Phone: 828-264-4545 Fax: 828-264-3279 | |
Mr. Gregory Allen Garth, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 895 State Farm Road, Suite 301, Boone, NC 28607 Phone: 828-265-4045 |